+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Diagnostic Enzymes Market by Type, Application, Product Type, and by Region - Global Forecast to 2022-2033

  • PDF Icon

    Report

  • 200 Pages
  • January 2023
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5717259
The diagnostic enzymes market size is estimated to be USD 4,907.1 million in 2022 and is expected to witness a CAGR of 4.17% during the forecast period 2023-2033. Surge in infectious and other chronic diseases, growing demand for enzymes in diagnostics, developments in viral infection diagnosis methods are some of the factors contributing to the market growth. Furthermore, increasing geriatric population globally and new discoveries and developments in the biotechnology field are other factors supporting the market growth. However, high sensitivity of enzymes to pH and temperature is expected to hinder the growth.

New discoveries and developments in the biotechnology field is expected to fuel the market growth during the projected period. For instance, CRISPR technology, which stands for clustered regularly interspaced short palindromic repeats, has expanded the applications of recombinant DNA technology in the pharmaceutical, medical, and other fields. The biotechnology industry has developed into one of the fastest-growing sectors over time due to recent R&D.

Increasing geriatric population globally is expected to propel the market growth during the forecast period. According to the United Nations' World Ageing Highlight for 2020, there were approximately 727 million individuals worldwide who were 65 and older, and by 2050, there will be 1.5 billion of them, which help the market for diagnostic enzymes increase.

Segmentation

By Type

The market is categorized into hot start Taq polymerase, RNAse inhibitors, HIV RT, Bst polymerase, UNG, acid phosphatase, lyophilized polymerase, Cas9 enzyme, T7 RNA polymerase, PCR master mix, alanine aminotransferase, glucose oxidase/glucose dehydrogenase and others. In 2022, the glucose oxidase/glucose dehydrogenase segment accounted for the highest revenue share due to its inherent biocompatibility, lack of toxicity, and unique catalysis against -d-glucose. Glucose oxidase is a common endogenous oxidoreductase present in all living things (GOx). The oxidation of glucose into gluconic acid and hydrogen peroxide (H2O2), which can be used to detect cancer biomarkers, can be efficiently accelerated by GOx in a variety of biosensors. Demand for glucose oxidase is expected to increase due to the enzyme's essential involvement in the diagnosis of diabetes. The segment for lactate oxidase is anticipated to increase at the fastest rate during the forecast period. This is due to the increasing use of molecular devices in the treatment of diabetes. In the cells of numerous living systems, lactate dehydrogenase (LDH) is widely distributed and catalysing the interconversion of lactate and pyruvate using the NAD+/NADH coenzyme system.

By Application

The market is categorized into oncology, diabetes, infectious diseases, cardiology, autoimmune diseases, nephrology, and others. In the global market, the infectious diseases segment accounted for the largest revenue share in 2022 owing to widespread use of PCR technology. Typical pneumonia, TB, streptococcal pharyngitis, ulcerative urogenital infections, and several chronic illnesses are all identified by PCR in the diagnosis of infectious disorders. The DNA polymerase gene expression in Thermus thermophilus Escherichia coli permits efficient reverse transcriptase activity for one-step detection of cellular mRNA expression. The oncology segment is anticipated to increase at the fastest rate throughout the projected period. The use of diagnostic enzymes in this market is driven by the widespread adoption of ISH techniques and the development of high-throughput technologies for the diagnosis of human tumors. The United States government launched the Cancer Moonshot in February 2022 with the objective of increasing cancer screening rates and locating cases that had been missed owing to the COVID-19 pandemic. The government intends to decrease the number of cancer deaths by 50% over the next 25 years by early detection and treatment, which will increase the need for cancer diagnostic enzyme testing.

By Product Type

The market is segmented into clinical enzymes and molecular enzymes. In 2022, the clinical enzymes segment accounted for the largest revenue share owing to growing usage of enzymes in clinical chemistry, which is connected to the analysis of body fluids for therapeutic and diagnostic purposes. A disorder that can be life-threatening may start to show minute variations in the amounts of body fluids including blood, plasma, or serum. As a result, clinical chemistry requires analytical methods that are fast, focused, and extremely sensitive. The selectivity and speed of the enzymes make them an essential component of clinical chemistry diagnostic processes. The substrate in an assay can be evaluated using enzyme specificity, or interferences can be eliminated from another process. Enzymes are additionally used to measure co-factors, inhibitors, and activators. Enzymes are also suitable for use as labels in immunoassay processes owing to their catalytic activity. The molecular market is anticipated to increase at a profitable rate. In molecular diagnostics, different enzymes are mostly used through methods including PCR tests, NGS assays, and others. One of the most popular molecular biology procedures is PCR. Diagnostic testing, sequencing, forensic analysis, and cloning are just a few of the sectors where the technology is being used more.

Regional Markets

In 2022, North America region accounted for the highest revenue in the diagnostic enzymes market and is expected to maintain its dominance during the forecast period. This is attributed to the increasing demand for enzymes and the rising incidence of infectious diseases. In order to deal with the pandemic, the FDA has approved COVID-19 laboratory-developed diagnostics for emergency use. The majority of these emergency usage authorizations also make use of RT-PCR-based testing and enzyme-linked immunosorbent assays for the identification of SARS-CoV-2. Asia Pacific is estimated to expand at the fastest rate during the projected period. Key manufacturers of diagnostic enzymes are expected to benefit from a potential growth platform in this region due to a number of factors, including the presence of a sizable target population, rising healthcare spending, high unmet clinical needs, expanding healthcare infrastructure, rising R&D activities for advanced diagnostic techniques, rising government initiatives, and developing healthcare infrastructure.

Competitor Insights

Some of the key players operating in the diagnostic enzymes market are Solis BioDyne., Takara Bio, Inc., Promega Corporation, Merck KGaA, Creative Enzyme, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Enzo Life Sciences, Inc., and Ambliqon A/S.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

For instance, Merck and Absci decided to collaborate on research to create novel enzymes in January 2022. It is anticipated that this strategy would improve Merck's biomanufacturing applications.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including type, application, and product type from 2023 to 2033.

Segmentation: Diagnostic Enzymes Market Report 2022 - 2033

Type (Revenue, USD Million), 2022 - 2033

  • Hot Start Taq Polymerase
  • RNAse Inhibitors
  • HIV RT
  • Bst Polymerase
  • UNG
  • Acid Phosphatase
  • Lyophilized Polymerase
  • Cas9 Enzyme
  • T7 RNA Polymerase
  • PCR Master Mix
  • Alanine Aminotransferase
  • Glucose Oxidase/Glucose Dehydrogenase
  • Others

Application (Revenue, USD Million), 2022 - 2033

  • Oncology
  • Diabetes
  • Infectious Diseases
  • Cardiology
  • Autoimmune Diseases
  • Nephrology
  • Others

Product Type (Revenue, USD Million), 2022 - 2033

  • Clinical Enzymes
  • Molecular Enzymes

By Region (Revenue, USD Million), 2022 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Framework
1.3.1. Research Models
1.3.1.1. Bottom-up Approach
1.3.1.2. Top-down Approach
1.3.1.3. Data Triangulation
1.3.2. Data Analysis
1.3.2.1. Data Validation
1.3.2.2. Market Size Estimation
1.3.2.3. Market Forecast Model

2. Introduction: Diagnostic Enzymes

3. Executive Summary

4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3

5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. SWOT Analysis

6. COVID-19 Impact Analysis: Diagnostic Enzymes Market

7. Market Analysis by Type
7.1. Hot Start Taq Polymerase
7.1.1. Hot Start Taq Polymerase Market Forecast, 2022-2033 (USD Million)
7.2. RNAse Inhibitors
7.2.1. RNAse Inhibitors Market Forecast, 2022-2033 (USD Million)
7.3. HIV RT
7.3.1. HIV RT Market Forecast, 2022-2033 (USD Million)
7.4. Bst Polymerase
7.4.1. Bst Polymerase Market Forecast, 2022-2033 (USD Million)
7.5. UNG
7.5.1. UNG Market Forecast, 2022-2033 (USD Million)
7.6. Acid Phosphatase
7.6.1. Acid Phosphatase Market Forecast, 2022-2033 (USD Million)
7.7. Lyophilized Polymerase
7.7.1. Lyophilized Polymerase Market Forecast, 2022-2033 (USD Million)
7.8. Cas9 Enzyme
7.8.1. Cas9 Enzyme Market Forecast, 2022-2033 (USD Million)
7.9. T7 RNA Polymerase
7.9.1. T7 RNA Polymerase Market Forecast, 2022-2033 (USD Million)
7.10. PCR Master Mix
7.10.1. PCR Master Mix Market Forecast, 2022-2033 (USD Million)
7.11. Alanine Aminotransferase
7.11.1. Alanine Aminotransferase Market Forecast, 2022-2033 (USD Million)
7.12. Others
7.12.1. Others Market Forecast, 2022-2033 (USD Million)

8. Market Analysis by Application
8.1. Oncology
8.1.1. Oncology Market Forecast, 2022-2033 (USD Million)
8.2. Diabetes
8.2.1. Diabetes Market Forecast, 2022-2033 (USD Million)
8.3. Infectious Diseases
8.3.1. Infectious Diseases Market Forecast, 2022-2033 (USD Million)
8.4. Cardiology
8.4.1. Cardiology Market Forecast, 2022-2033 (USD Million)
8.5. Autoimmune Diseases
8.5.1. Autoimmune Diseases Market Forecast, 2022-2033 (USD Million)
8.6. Nephrology
8.6.1. Nephrology Market Forecast, 2022-2033 (USD Million)
8.7. Others
8.7.1. Others Market Forecast, 2022-2033 (USD Million)

9. Market Analysis by Product Type
9.1. Clinical Enzymes
9.1.1. Clinical Enzymes Market Forecast, 2022-2033 (USD Million)
9.2. Molecular Enzymes
9.2.1. Molecular Enzymes Market Forecast, 2022-2033 (USD Million)

8. Regional Market Analysis
8.1. Regional Market Trends Analysis

9. North America Diagnostic Enzymes Market
9.1. North America Diagnostic Enzymes Market
9.1.1. North America Market Size and Forecast, 2022-2033 (USD Million)
9.1.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
9.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
9.1.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
9.2. U.S. Diagnostic Enzymes Market
9.2.1. U.S. Market Size and Forecast, 2022-2033 (USD Million)
9.2.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
9.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
9.2.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
9.3. Canada Diagnostic Enzymes Market
9.3.1. Canada Market Size and Forecast, 2022-2033 (USD Million)
9.3.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
9.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
9.3.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)

10. Europe Diagnostic Enzymes Market
10.1. Europe Diagnostic Enzymes Market
10.1.1. Europe Market Size and Forecast, 2022-2033 (USD Million)
10.1.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.1.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
10.2. Germany Diagnostic Enzymes Market
10.2.1. Germany Market Size and Forecast, 2022-2033 (USD Million)
10.2.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.2.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
10.3. UK Diagnostic Enzymes Market
10.3.1. UK Market Size and Forecast, 2022-2033 (USD Million)
10.3.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.3.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
10.4. France Diagnostic Enzymes Market
10.4.1. France Market Size and Forecast, 2022-2033 (USD Million)
10.4.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.4.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
10.5. Spain Diagnostic Enzymes Market
10.5.1. Spain Market Size and Forecast, 2022-2033 (USD Million)
10.5.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.5.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.5.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
10.6. Italy Diagnostic Enzymes Market
10.6.1. Italy Market Size and Forecast, 2022-2033 (USD Million)
10.6.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.6.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.6.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
10.7. Rest of Europe Diagnostic Enzymes Market
10.7.1. Rest of Europe Market Size and Forecast, 2022-2033 (USD Million)
10.7.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.7.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.7.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)

11. Asia Pacific Diagnostic Enzymes Market
11.1. Asia Pacific Diagnostic Enzymes Market
11.1.1. Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
11.1.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.1.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
11.2. Japan Diagnostic Enzymes Market
11.2.1. Japan Market Size and Forecast, 2022-2033 (USD Million)
11.2.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.2.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
11.3. China Diagnostic Enzymes Market
11.3.1. China Market Size and Forecast, 2022-2033 (USD Million)
11.3.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.3.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
11.4. India Diagnostic Enzymes Market
11.4.1. India Market Size and Forecast, 2022-2033 (USD Million)
11.4.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.4.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
11.5. South Korea Diagnostic Enzymes Market
11.5.1. South Korea Market Size and Forecast, 2022-2033 (USD Million)
11.5.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.5.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.5.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
11.6. Australia Diagnostic Enzymes Market
11.6.1. Australia Market Size and Forecast, 2022-2033 (USD Million)
11.6.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.6.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.6.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
11.7. Rest of Asia Pacific Diagnostic Enzymes Market
11.7.1. Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
11.7.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.7.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.7.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)

12. Latin America Diagnostic Enzymes Market
12.1. Latin America Diagnostic Enzymes Market
12.1.1. Latin America Market Size and Forecast, 2022-2033 (USD Million)
12.1.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.1.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
12.2. Brazil Diagnostic Enzymes Market
12.2.1. Brazil Market Size and Forecast, 2022-2033 (USD Million)
12.2.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.2.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
12.3. Mexico Diagnostic Enzymes Market
12.3.1. Mexico Market Size and Forecast, 2022-2033 (USD Million)
12.3.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.3.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
12.4. Argentina Diagnostic Enzymes Market
12.4.1. Argentina Market Size and Forecast, 2022-2033 (USD Million)
12.4.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.4.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
12.5. Rest of Latin America Diagnostic Enzymes Market
12.5.1. Rest of Latin America Market Size and Forecast, 2022-2033 (USD Million)
12.5.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.5.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.5.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)

13. MEA Diagnostic Enzymes Market
13.1. MEA Diagnostic Enzymes Market
13.1.1. MEA Market Size and Forecast, 2022-2033 (USD Million)
13.1.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
13.1.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.1.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
13.2. GCC Diagnostic Enzymes Market
13.2.1. GCC Market Size and Forecast, 2022-2033 (USD Million)
13.2.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
13.2.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.2.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
13.3. South Africa Diagnostic Enzymes Market
13.3.1. South Africa Market Size and Forecast, 2022-2033 (USD Million)
13.3.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
13.3.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.3.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)
13.4. Rest of MEA Diagnostic Enzymes Market
13.4.1. Rest of MEA Market Size and Forecast, 2022-2033 (USD Million)
13.4.1.1. Market Size and Forecast by Type, 2022-2033 (USD Million)
13.4.1.2. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.4.1.3. Market Size and Forecast by Product Type, 2022-2033 (USD Million)

14. Competitor Analysis
14.1. Market Share Analysis, 2022
14.2. Major Recent Developments, 2019-2022

15. Company Profiles
15.1. Solis BioDyne
15.1.1. Company Snapshot
15.1.2. Company Overview
15.1.3. Financial Analysis
15.1.4. Product Benchmarking
15.1.5. Recent Developments
15.2. Takara Bio Inc.
15.2.1. Company Snapshot
15.2.2. Company Overview
15.2.3. Financial Analysis
15.2.4. Product Benchmarking
15.2.5. Recent Developments
15.3. Promega Corporation
15.3.1. Company Snapshot
15.3.2. Company Overview
15.3.3. Financial Analysis
15.3.4. Product Benchmarking
15.3.5. Recent Developments
15.4. Merck KGaA
15.4.1. Company Snapshot
15.4.2. Company Overview
15.4.3. Financial Analysis
15.4.4. Product Benchmarking
15.4.5. Recent Developments
15.5. Creative Enzyme
15.5.1. Company Snapshot
15.5.2. Company Overview
15.5.3. Financial Analysis
15.5.4. Product Benchmarking
15.5.5. Recent Developments
15.6. F. Hoffmann-La Roche Ltd
15.6.1. Company Snapshot
15.6.2. Company Overview
15.6.3. Financial Analysis
15.6.4. Product Benchmarking
15.6.5. Recent Developments
15.7. Thermo Fisher Scientific, Inc.
15.7.1. Company Snapshot
15.7.2. Company Overview
15.7.3. Financial Analysis
15.7.4. Product Benchmarking
15.7.5. Recent Developments
15.8. Enzo Life Sciences, Inc.
15.8.1. Company Snapshot
15.8.2. Company Overview
15.8.3. Financial Analysis
15.8.4. Product Benchmarking
15.8.5. Recent Developments
15.9. Ambliqon A/S
15.9.1. Company Snapshot
15.9.2. Company Overview
15.9.3. Financial Analysis
15.9.4. Product Benchmarking
15.9.5. Recent Developments
15.10. Company 10
15.10.1. Company Snapshot
15.10.2. Company Overview
15.10.3. Financial Analysis
15.10.4. Product Benchmarking
15.10.5. Recent Developments
15.11. Company 11
15.11.1. Company Snapshot
15.11.2. Company Overview
15.11.3. Financial Analysis
15.11.4. Product Benchmarking
15.11.5. Recent Developments
15.12. Company 12
15.12.1. Company Snapshot
15.12.2. Company Overview
15.12.3. Financial Analysis
15.12.4. Product Benchmarking
15.12.5. Recent Developments
15.13. Company 13
15.13.1. Company Snapshot
15.13.2. Company Overview
15.13.3. Financial Analysis
15.13.4. Product Benchmarking
15.13.5. Recent Developments
15.14. Company 14
15.14.1. Company Snapshot
15.14.2. Company Overview
15.14.3. Financial Analysis
15.14.4. Product Benchmarking
15.14.5. Recent Developments
15.15. Company 15
15.15.1. Company Snapshot
15.15.2. Company Overview
15.15.3. Financial Analysis
15.15.4. Product Benchmarking
15.15.5. Recent Developments

16. Conclusion

17. Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Solis BioDyne.
  • Takara Bio Inc.
  • Promega Corporation
  • Merck KGaA
  • Creative Enzyme
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Enzo Life Sciences Inc.
  • Ambliqon A/S.